Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We do have the cryptic "watch this space" comment too.
Grrr, are we nearly there yet?
:-)
I don't know wellsite. Just trying to get some views I suppose.
I think we are all sure By-Health are behind the articles and they are probably to raise awareness of Fruitflow but from what we know they still have regulatory submission to the SAMR to apply for so any BH FF product launch isn't round the corner and they have to wait till 1-1-2023 before the can sell FF as distributors.
I guess my thought is, why raise awareness now and not closer to a product launch? Or is there something we don't know about happening in the background?
ditto ditto
Or is there something else behind them???
What are you thinking ?
W:-)
Ditto
Very encouraging to see the amount of promo work being published. The By Health evidence based support work is impressive.
Keep them coming Gixer, great work
Todays articles. (if anyone is still reading them)
"The incidence of cardiovascular and cerebrovascular problems is increased. Can water-soluble tomato concentrate (new complex) prevent cerebral thrombosis"
https://tech-ifeng-com.translate.goog/c/8Gao5YfbEUr?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
"Heart attack danger! Water-soluble tomato concentrate (new complex) "escorts" your cardiovascular health"
https://tech-ifeng-com.translate.goog/c/8GbPD3DrejR?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
I must admit, I thought they would have stopped by now but they just keep coming.
Even if some are repeated or it looks like the content is the same as previous articles, its helping build awareness of Water-soluble tomato concentrate (new complex) in China and that can only be a good thing.
Or is there something else behind them???
I don't understand that ,what's it got to do with the trades in 2020 ,were in 2022
From June 2020 someone has been cautiously buying , some clever traders have been doing well too.
https://www.tradingview.com/x/YJpVBzcJ/
If you check under cardiovascular you will also find it.
Exact same wording so don't know if the companies are connected or it's a dsm premix.
https://www.google.co.uk/url?sa=t&source=web&rct=j&url=https://swissnutritionsolutions.ch/en/food-supplements/&ved=2ahUKEwi4vdiNyZT4AhUNhFwKHQ8YAQcQFnoECBoQAQ&usg=AOvVaw0kWZ4PonisL9c1i-3BrbFZ
toot
these are US based, B2B suppliers
https://believepharmaceutical.com/cardiovascular
Capsules with WSTC II (Fruitflow®), vitamin C, pomegranate extract and vitamin E.
believepharmaceutical.com was first indexed by Google in December 2021
The FF combo looks familiar but can't track down the retail product
W$
Thing is, the only snippets of anything right now are coming from China. I don't think anyone has forgotten about the rest of the world or the PXS DSM negotiations for the new agreement but until there is something to post...........
Looks as though everyone has placed all the hope on China, of course it is a huge market and to do well there would be massive, but have we given up elsewhere, sales must be improving in the markets we are already active.
When China SAMR approval is in place and large orders are in the bag.
All these articles are fantastic ,but when will we see the sp reflect this
Another
A masterpiece of tomato! Sun Yat-Sen University Experiment: Water-soluble Tomato Concentrate Can Help Cardiovascular Health.
https://www-163-com.translate.goog/dy/article/H9019DDS0552QWC0.html?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
The funding is also v.interesting.
This work was supported by the National Natural Science Foundation of China (Nos. 82030098, 81872617, and 81730090), Shenzhen Science, Technology, and Innovation Commission (No. JCYJ20180307153228190), By-health Research Foundation and Scientific Research Foundation of Chinese Nutrition Society – DSM Scientific Research Foundation (No. 5800071020001). The funders did not participate in the design, data collection, data analysis, interpretation of the clinical trial, and the writing of this manuscript.
Slam, This is what By-Health say about the intellectual property regarding Fruitflow.
"(2) During the period of the drug research and development agreement, Provexis and the company will cooperate in drug research and development projects according to the terms of this agreement, and the company has the exclusive right to research and development of drugs in the agreement area. (3) With regard to intellectual property rights, each party shall at all times be the owner of all knowledge owned by each party prior to entering into this Agreement or independently created outside the scope of this Agreement (“Background Intellectual Property Rights”); further, this Agreement The implementation of this will not result in the transfer of background intellectual property rights by either party to the other."
https://data-eastmoney-com.translate.goog/notices/detail/300146/AN202111051527225504.html?_x_tr_sch=http&_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
By Health are funding an awful lot of studies on the differing effects of WSTE, and Some of these studies would appear to be pushing the use of WTSE into mainstream medicine too.
I sometimes wonder who will own the IP rights for some of these results. I am not sure that it matters too much as Provexis do own the parent IP.
Whatever way it turns out, BH are certainly pushing the awareness of WTSE (at least to the Chinese population and that can only be good for us in the long (or even medium) term.
"secondary prevention of WTE on individuals with metabolic diseases merits further clinical study."
And then there is this.
"Water-soluble tomato extract improves platelet function in subjects with metabolic syndrome: a randomized clinical trial"
Source(s) of funding: BY-HEAITH CO.,LTD
Target disease: metabolic syndrome
Study execute time: From2020-12-01To 2022-12-31
Objectives of Study:
"Metabolic syndrome induced platelet hyper-activation and hyper-aggregation, which plays an important role in the pathological process of CVD. Water-soluble tomato extract can inhibit platelet activation and aggregation in vitro and in healthy adult. However, the effect of water-soluble tomato extract on platelet function in subjects with metabolic syndrome are unclear. The present study intends to investigate the effect of water-soluble tomato extract on platelet function and dose-response in individual with metabolic syndrome."
http://www.chictr.org.cn/showprojen.aspx?proj=64530
Following on from the Conclusion that DP64 posted. A couple of bits that caught my attention.
Primary prevention.
"This evidence indicated that daily intake of WTE is safe in Chinese healthy middle-aged and older individuals, and it has the potential to be applied for primary prevention of CVDs."
Secondary Prevention.
"The findings of our study which focused on Chinese healthy middle-aged and older individuals just indicate a potential benefit for primary prevention of CVDs in Chinese healthy middle-aged and older individuals, and the primary or secondary prevention of WTE on individuals with metabolic diseases merits further clinical study."
Many thanks gixer.
DP64, the last RNS a couple of days ago on the 31st tells us that five are completed.
Hi gixer,
As you are following very closely about the By Health development. So out of 8/9 study they need for SAMR approval how many they have completed? I believe all these are part of that study. Any thoughts about it will be very much appreciated.